HOCHUL SIGNS CONDITIONAL CANNABIS CULTIVATION BILL

Governor Kathy Hochul today signed legislation creating a new Conditional Adult-use Cannabis Cultivator license, establishing a pathway for existing New York hemp farmers to apply for a conditional license to grow cannabis in the 2022 growing season for the forthcoming adult-use cannabis market. Under the law, conditionally licensed cannabis farmers must meet certain requirements, including safe, sustainable and environmentally friendly cultivation practices, participation in a social equity mentorship program, and engagement in a labor peace agreement with a bona fide labor organization.   

“I am proud to sign this bill, which positions New York’s farmers to be the first to grow cannabis and jumpstart the safe, equitable and inclusive new industry we are building,” Governor Hochul said. “New York State will continue to lead the way in delivering on our commitment to bring economic opportunity and growth to every New Yorker in every corner of our great state.”   

Assembly Majority Leader Crystal Peoples-Stokes said, “Last year, after many years of fighting, we finally enacted the Marijuana Regulation and Taxation Act, and are beginning to undo the devastating impacts over ninety years of unequal enforcement of marijuana prohibition had on too many lives and communities. MRTA ensures that the legal adult-use market will be centered on equity and economic justice for communities of color and individuals that have been harmed most by the War on Drugs in the State of New York. With the passage of this bill, we have the opportunity to create a responsible start to the adult-use cannabis industry by authorizing temporary conditional cultivator and processor licenses to current New York hemp farmers. This authority will help secure enough safe, regulated, and environmentally conscious cannabis products to meet the demand of the adult-use cannabis market when retail dispensaries open. Importantly, this legislation calls for a Social Equity Mentorship Program, which will create a viable and inclusive path for social and economic equity partners interested in cannabis cultivation and processing to gain invaluable knowledge and experience in this emerging industry. The temporary conditional licenses authorized by this bill will ultimately help realize the vision and goals of the MRTA.” 

With a conditional adult-use cannabis cultivation license, farmers can grow outdoors or in a greenhouse for up to two years from the issuance of the license. It also allows them to manufacture and distribute cannabis flower products without holding an adult-use processor or distributor license, until June 1, 2023. Cultivators are limited to one acre (43,560 square feet) of flowering canopy outdoors or 25,000 square feet in a greenhouse and can use up to 20 artificial lights. They can also split between outdoor and greenhouse grows with a maximum total canopy of 30,000 square feet as long as green house flowering canopy remains under 20,000 square feet.   

The OCM will be developing a license application process and opening the program as soon as possible. To qualify for an Adult-use Cannabis Conditional Cultivator License an applicant must have been an authorized industrial hemp research partner for the Department of Agriculture and Markets, cultivating hemp for its non-intoxicating cannabinoid content for at least two of the past four years and in good standing as of December 31, 2021, when the research program ended. 

Holders of the license must also participate in a social equity mentorship program where they provide training in cannabis cultivation and processing for social and economic equity partners, preparing them for potential roles in the industry. Growers will also have to meet sustainability requirements to ensure the cannabis is grown in an environmentally conscientious way.   

The Governor’s action today builds on the quick work she and the OCM have undertaken to bring the new cannabis industry to life in New York. In January , the Governor’s Executive Budget proposed a $200 million program that will use industry licensing fees and revenue to provide support to eligible applicants from communities impacted by the overcriminalization of cannabis during its prohibition. The Governor and the Legislature also moved quickly to appoint the Cannabis Control Board and OCM leadership within weeks of the start of her administration. Since the Board held its first meeting on Oct. 5, the OCM has:   

  • Launched the Cannabinoid Hemp Program, putting in place protections for the public and provisions to help New York’s CBD businesses compete;  
  • Vastly expanded access to the Medical Cannabis Program, including empowering health care providers to determine if medical cannabis can help their patients, lowering costs by permanently waiving patient fees and allowing the sale of whole flower, and growing the list of providers who can certify patients; and  
  • Launched its first wave of community outreach events with 11 regional events, including one in Spanish, that’s already engaged more than 5,000 attendees; and  
  • Developed a pipeline of talented professionals to join the Office’s growing team and built the infrastructure to support the office.   

Related articles

Did acting AG Todd Blanche say predators won’t be prosecuted in Epstein case? There’s no proof

Blanche denied having enough evidence to prosecute men from the Epstein files, but not in the way some social media users suggested.

Hochul’s Dear Tom letter

Gov. Kathy Hochul wants assurances from President Donald Trump’s administration that a very specific federal immigration officer isn’t operating in New York.

Posts claim Trump appointed Ghislaine Maxwell’s former defense attorney as acting AG. Here’s the real story

Trump appointed Todd Blanche, his former defense attorney, as acting attorney general in April 2026.

Stricken cruise ship marooned as deadly rat-borne virus spreads



A rat-borne virus that broke out aboard a cruise ship off the coast of Cape Verde, West Africa, is now suspected to have spread to seven people, according to reports.

The World Health Organization, or WHO, confirmed two cases and suspects five others aboard the MV Hondius cruise. Of them, one patient who is critically ill and three others with mild symptoms. Three people have already died.

The dead include two senior Dutch passengers and a German national.

The Dutch cruise ship paused its weeks-long journey to Argentina, Antarctica and other islands in the South Atlantic, and has been waiting for help after Cape Verde authorities denied passengers the right to disembark due to public health concerns, reports The Seattle Times and The Associated Press.

According to the Daily Beast, the outbreak began between April 6 and April 28. Symptoms include fever and gastrointestinal issues. In severe cases, it can result in pneumonia, respiratory failure and shock.

The WHO said passengers were asked to stay in their cabins and, “limit their risk while disinfection and other measures are being taken,” according to The Seattle Times and AP.

The U.S. Centers for Disease Control and Prevention reported that the Hantavirus has a high fatality rate, adding that it's typically transmitted to humans through exposure to rodent feces.

The Daily Beast reported that, although most strains do not spread between people, a rare variant found in parts of Argentina and Chile’s Andes has shown otherwise.

“We do know that some of the cases had very close contact with each other and certainly human-to-human transmission can’t be ruled out so, as a precaution, this is what we are assuming,” Dr. Maria Van Kerhove, WHO’s Director for Epidemic and Pandemic Preparedness and prevention, said.

Van Kerhove added, “The risk to the general public is low.”

The Seattle Times and AP reported authorities in Cape Verde sent teams of doctors, surgeons, nurses and laboratory specialists to provide the vessel with medical support.

“The outbreak is being managed through coordinated international response, and includes in-depth investigations, case isolation and care, medical evacuation and laboratory investigations,” said a WHO representative.